Stay updated on Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.

Latest updates to the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page
- Check7 days agoChange DetectedThe page no longer lists 'Multiple myeloma' as a topic and removes the MedlinePlus Genetics related topic. This reduces the disease context and related resource links shown on the page.SummaryDifference0.1%

- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the previous government funding lapse/operating status notice (Revision: v3.4.1).SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a site-wide government funding/status notice and updated the references to include the CEPHEUS trial citation; removed the erratum note associated with that citation.SummaryDifference0.2%

- Check28 days agoChange DetectedGlossary enhancements and related topic links (e.g., Multiple myeloma, MedlinePlus Genetics) were added. Metadata updates include changes to QC-related labels and versioning (Revision: v3.4.0) and removal of older QC wording.SummaryDifference0.2%

- Check35 days agoChange DetectedUpdated study record with new update dates (2026-01-15 and 2026-01-20) and removed outdated related topics; no substantive changes to trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedPage metadata updated to Revision v3.3.4, replacing the previous Revision v3.3.3; these are administrative version updates that do not affect trial details or user interactions.SummaryDifference0.0%

Stay in the know with updates to Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.